Literature DB >> 26055853

Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies.

Michel Wassef1, Francine Blei2, Denise Adams3, Ahmad Alomari4, Eulalia Baselga5, Alejandro Berenstein6, Patricia Burrows7, Ilona J Frieden8, Maria C Garzon9, Juan-Carlos Lopez-Gutierrez10, David J E Lord11, Sally Mitchel12, Julie Powell13, Julie Prendiville14, Miikka Vikkula15.   

Abstract

Vascular anomalies represent a spectrum of disorders from a simple "birthmark" to life- threatening entities. Incorrect nomenclature and misdiagnoses are commonly experienced by patients with these anomalies. Accurate diagnosis is crucial for appropriate evaluation and management, often requiring multidisciplinary specialists. Classification schemes provide a consistent terminology and serve as a guide for pathologists, clinicians, and researchers. One of the goals of the International Society for the Study of Vascular Anomalies (ISSVA) is to achieve a uniform classification. The last classification (1997) stratified vascular lesions into vascular malformations and proliferative vascular lesions (tumors). However, additional disease entities have since been identified that are complex and less easily classified by generic headings, such as capillary malformation, venous malformation, lymphatic malformation, etc. We hereby present the updated official ISSVA classification of vascular anomalies. The general biological scheme of the classification is retained. The section on tumors has been expanded and lists the main recognized vascular tumors, classified as benign, locally aggressive or borderline, and malignant. A list of well-defined diseases is included under each generic heading in the "Simple Vascular Malformations" section. A short definition is added for eponyms. Two new sections were created: one dealing with the malformations of individually named vessels (previously referred to as "truncular" malformations); the second groups lesions of uncertain or debated nature (tumor versus malformation). The known genetic defects underlying vascular anomalies are included in an appendix. This classification is meant to be a framework, acknowledging that it will require modification as new scientific information becomes available.
Copyright © 2015 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2015        PMID: 26055853     DOI: 10.1542/peds.2014-3673

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  187 in total

Review 1.  Clinical and sonographic features of pediatric soft-tissue vascular anomalies part 2: vascular malformations.

Authors:  Craig M Johnson; Oscar M Navarro
Journal:  Pediatr Radiol       Date:  2017-08-04

Review 2.  Molecules in medicine mini-review: isoforms of PI3K in biology and disease.

Authors:  Bart Vanhaesebroeck; Maria A Whitehead; Roberto Piñeiro
Journal:  J Mol Med (Berl)       Date:  2015-12-10       Impact factor: 4.599

Review 3.  New and Emerging Targeted Therapies for Vascular Malformations.

Authors:  An Van Damme; Emmanuel Seront; Valérie Dekeuleneer; Laurence M Boon; Miikka Vikkula
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

4.  Glomuvenous Malformation of the Neck.

Authors:  Muhammad Salman Khan; Amir Humza Sohail; Kiran Hilal; Muhammad Hassaan Arif Maan
Journal:  Int J Angiol       Date:  2019-08-06

5.  [Vascular anomalies. Part II: vascular malformations].

Authors:  S Mylonas; S Brunkwall; J Brunkwall
Journal:  Chirurg       Date:  2018-04       Impact factor: 0.955

6.  Parapharyngeal Space Venous Malformation: An Imaging Mimic of Pleomorphic Adenoma.

Authors:  C M Tomblinson; G P Fletcher; T K Lidner; C P Wood; S M Weindling; J M Hoxworth
Journal:  AJNR Am J Neuroradiol       Date:  2018-11-08       Impact factor: 3.825

Review 7.  Female Pelvic Vascular Malformations.

Authors:  Aparna Annam
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

8.  Ethanolgel sclerotherapy of venous malformations improves health-related quality-of-life in adults and children - results of a prospective study.

Authors:  Walter A Wohlgemuth; Rene Müller-Wille; Veronika Teusch; Simone Hammer; Moritz Wildgruber; Wibke Uller
Journal:  Eur Radiol       Date:  2016-10-04       Impact factor: 5.315

9.  Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly.

Authors:  Dong Li; Tara L Wenger; Christoph Seiler; Michael E March; Alvaro Gutierrez-Uzquiza; Charlly Kao; Elizabeth Bhoj; Lifeng Tian; Misha Rosenbach; Yichuan Liu; Nora Robinson; Mechenzie Behr; Rosetta Chiavacci; Cuiping Hou; Tiancheng Wang; Marina Bakay; Renata Pellegrino da Silva; Jonathan A Perkins; Patrick Sleiman; Michael A Levine; Patricia J Hicks; Maxim Itkin; Yoav Dori; Hakon Hakonarson
Journal:  Hum Mol Genet       Date:  2018-09-15       Impact factor: 6.150

10.  Initial Experience With Propranolol Treatment of Lymphatic Anomalies: A Case Series.

Authors:  June K Wu; Ellen D Hooper; Sherelle L Laifer-Narin; Lynn L Simpson; Jessica Kandel; Carrie J Shawber
Journal:  Pediatrics       Date:  2016-08-25       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.